Next Steps for Progressive Stem Cell Politics
By Marcy Darnovsky,
Science Progress
| 12. 16. 2008
The long-awaited stem cell announcement expected soon after inauguration day will be a welcome corrective to the Bush administration’s restrictions. As we anticipate a new policy—one that loosens federal funding for research using stem cell lines created with in vitro fertilization embryos not needed for reproductive purposes—let’s also take a good look at how to change the politics of stem cell research.
For the past eight years, the stem cell debate has been notable for its divisiveness. Controversy formed along the embryo divide; many liberals and progressives came to their positions in reaction to the Bush stem cell policy and the theological beliefs that helped motivate it.
In several election cycles, embryonic stem cell research became both hot potato and partisan wedge. Opponents persisted in absolutist rejection, while supporters countered with promises of imminent cures for diseases that, in a frequent hyperbolic refrain, “affect 128 million Americans.” The din of the stem cell war all but drowned out discussion of the non-embryo issues that stem cell research can pose.
But we should be able to conduct stem cell politics—and science...
Related Articles
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...